tiprankstipranks
Advertisement
Advertisement
PolyPid Begins FDA NDA Submission for D-PLEX₁₀₀ to Prevent Surgical Infections
PremiumCompany AnnouncementsPolyPid Begins FDA NDA Submission for D-PLEX₁₀₀ to Prevent Surgical Infections
2M ago
PolyPid’s Moment Is Here: NDA Submission Begins as a High-Impact Catalyst Stack Takes Shape (NASDAQ: PYPD)
Premium
TipRanks Newswire
PolyPid’s Moment Is Here: NDA Submission Begins as a High-Impact Catalyst Stack Takes Shape (NASDAQ: PYPD)
2M ago
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
Premium
TipRanks Newswire
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
2M ago
Ten new option listings and two option delistings on January 22nd
PremiumThe FlyTen new option listings and two option delistings on January 22nd
4M ago
PolyPid Calls February 2026 Extraordinary Meeting to Approve Board Chair Compensation
Premium
Company Announcements
PolyPid Calls February 2026 Extraordinary Meeting to Approve Board Chair Compensation
5M ago
PolyPid Appoints Brooke Story as Chairman Amid Strategic Growth
Premium
Company Announcements
PolyPid Appoints Brooke Story as Chairman Amid Strategic Growth
5M ago
PolyPid Expands Share Offering to Strengthen Financial Position
PremiumCompany AnnouncementsPolyPid Expands Share Offering to Strengthen Financial Position
6M ago
PolyPid price target lowered to $9 from $10 at Roth Capital
Premium
The Fly
PolyPid price target lowered to $9 from $10 at Roth Capital
7M ago
PolyPid Ltd. Advances Towards Key Milestones in 2025
Premium
Company Announcements
PolyPid Ltd. Advances Towards Key Milestones in 2025
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100